Press Releases

Health care research and innovation collaborative Optum Labs selected as primary research partner

Washington, DC – The Global CEO Initiative on Alzheimer’s Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and innovation to public and private research agendas aimed at redefining care delivery and changing the way future generations are affected by Alzheimer’s disease.

Washington, DC – UK Prime Minister David Cameron announced new plans on Saturday to tackle dementia in the “The Prime Minister’s Challenge on Dementia 2020,” the UK Government’s bold dementia agenda for the next five years.  The Challenge envisions that by 2020 England will be the global leader in dementia care and research related to dementia and other neurodegenerative diseases.  The Government will spend 3 million pounds (US $4.6 milli

Washington, DC – George Vradenburg, Chairman and Co-founder of USAgainstAlzheimer’s, today praised Dr. Margaret Hamburg, who announced that she is stepping down as the Commissioner of the Food and Drug Administration (FDA) in March.

Washington, DC -- USAgainstAlzheimer’s, an entrepreneurial and disruptive advocacy organization demanding greater urgency in the fight against Alzheimer's, expressed disappointment in the Administration’s FY 2016 Budget proposal, which fails to provide the necessary resources for Alzheimer’s research to prevent and treat the disease by 2025, our national goal.

Washington, DC – USAgainstAlzheimer’s, an entrepreneurial and disruptive advocacy organization demanding greater urgency in the fight against Alzheimer's, urges the 114th Congress to prioritize funding for Alzheimer’s disease research and related programs as it sets out its agenda for the year.

Pages

^ Back to Top